Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-11
2006-04-11
Campell, Bruce H. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S003100, C514S021800
Reexamination Certificate
active
07026284
ABSTRACT:
The present invention proposes formative agent of protein complex, in which a polyphenol is useful component, and the agent is useful as gene complex, cell adhesion inhibitor or immune tolerogen. The polyphenol of forming the agent is selected from catechin group consisting of epigallocatechin-gallate, tannic acids, or proanto-dianisidine, a protein of the protein complex is selected from proteins consisting of animal proteins composed of polypeptide chain of peptide-combined amino acids, vegetative proteins, nucleus proteins, glycogen proteins, lipo-proteins and metal proteins, the gene complex comprises by compositing genes by polyphenol catechins in order to introduce genes to cells of animals or human bodies, a cell composed of the cell adhesion inhibitor is selected from cells consisting of an animal cell including a stem cell, skin cell, mucosa cell, hepatocyte, islet cell, neural cell, cartilage cell, endothelial cell, epidermal cell, osteocyte or muscle cell isolated from human or animal organism, or sperm, ovum or fertilized egg of domestic animals or fishes and a tissue or an organ for transplantation of the immune tolerogen is selected from the tissue or the organ consisting of skin, blood vessel, cornea, kidney, heart, liver, umbilical cord, bowels, nerve, lung, placenta or pancreas.
REFERENCES:
patent: 4517175 (1985-05-01), Iwabuchi et al.
patent: 5952023 (1999-09-01), Lehmberg et al.
patent: 296 23 606 (1999-07-01), None
patent: 1 057 405 (2000-12-01), None
patent: 64-027471 (1989-01-01), None
patent: 02202900 (1990-08-01), None
patent: 06122631 (1994-05-01), None
patent: 8-283151 (1996-10-01), None
patent: 10-158184 (1998-06-01), None
patent: 11-075887 (1999-03-01), None
patent: 11-276162 (1999-10-01), None
patent: 2001031669 (2001-02-01), None
Chai Salon, http://www.chaisalon.com/Recipes/recipes.htm.
The Chemistry of Tea http://www.teatalk.com/science/chemistry.htm.
Rita V. Copelman, Leather and Hides, http://members.aol.com/—ht—a/centralprr/fazio/page9a.htm.
Nemours Foundation for Kids Health for Parents Milk Allergy, http://kidshealth.org/parent/medical/allergies/milk—allergy.html.
National Cancer Institute “Prevention Agents,” http://www3.cancer.gov/prevention/agents/Tea—Polyphenols.html.
Hirofumi Tachibana, et al.; “Identification of a Methylated Tea Catechin as an Inhibitor of Degranulation in Human Basophilic KU812 Cells”; Biosci. Biotechnol. Biochem., 64 (2), 452-454, 2000.
L. Berrens, et al.; “Complement Inactivation By Allergenic Plant Pollen Extracts”; Life Sciences, vol. 60, No. 17, pp. 1497-1503, 1997.
BMG Incorporated
Campell Bruce H.
Heard Thomas S.
Jordan and Hamburg LLP
LandOfFree
Formative agent of protein complex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formative agent of protein complex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formative agent of protein complex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3615085